Fisher & Paykel Healthcare Corporation (ASX: FPH) has launched the F&P Solo mask in for the treatment of obstructive sleep apnea (OSA).
F&P Solo is a world-first AutoFit nasal and pillows mask which simplifies the setup process, enabling users to stretch the mask onto the face and adjust it into place with one touch.
“F&P Solo represents a significant step forward in mask innovation,” said Lewis Gradon, Managing Director and Chief Executive Officer for Fisher & Paykel Healthcare.
“Our team has been uncompromising in its focus on patient outcomes, and we believe this mask makes the setup and fit process easier than ever. We’ve begun with a market release in New Zealand and Australia, and more markets will follow in the coming months.”
Without conventional straps to undo and pull, the mask reduces overtightening on the face. AutoLock technology holds the mask in place with minimal force and dynamically responds to sleep movement and CPAP-therapy pressure.
“Patients can set themselves up without assistance and then easily finetune the mask during nightly use for an optimal fit,” said Andrew Somervell, VP Products and Technology. “Our focus on what’s best for the patient led us here – we sought a result that optimises for both comfort and simplicity, and we believe F&P Solo delivers on this.”
Sales of F&P Solo have commenced in New Zealand and will begin in Australia at the end of October. Launches into Europe, Canada and the United States are set to follow in the coming months.
Nasal and pillows cushions can be bought individually, allowing users to interchange. The headgear is one size, with four different nasal cushion sizes (small, medium, large and wide) and three different pillows cushion sizes (small, medium and large).
The mask is supported by positive clinical trial results: